艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABBV 艾伯维公司

盘后交易 08-11 19:52:44 EDT

250.09

+2.12

+0.85%

盘后250.00

-0.09-0.04%

19:37 EDT

最高250.77	最低247.18	成交量448.55万
今开248.14	昨收247.97	日振幅1.45%
总市值4,420亿	流通市值4,409亿	总股本17.67亿
成交额11.19亿	换手率0.25%	流通股本17.63亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABBV","market":"US","secType":"STK","nameCN":"艾伯维公司","latestPrice":250.09,"timestamp":1786478400000,"preClose":247.97,"halted":0,"volume":4485450,"hourTrading":{"tag":"盘后","latestPrice":250,"preClose":250.09,"latestTime":"19:37 EDT","volume":220292,"amount":55092700.71356,"timestamp":1786491428582,"change":-0.09,"changeRate":-0.00036,"amplitude":0.005118},"delay":0,"changeRate":0.008549421300963844,"floatShares":1762950764,"shares":1767384632,"eps":3.539701,"marketStatus":"盘后交易","change":2.12,"latestTime":"08-11 19:52:44 EDT","open":248.14,"high":250.765,"low":247.18,"amount":1119047783.5275,"amplitude":0.014457,"askPrice":250.05,"askSize":10,"bidPrice":248,"bidSize":10,"shortable":3,"etf":0,"ttmEps":3.539701,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1786492800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":247.97,"dividendRate":0.02731,"preHourTrading":{"tag":"盘前","latestPrice":248.05,"preClose":247.97,"latestTime":"09:29 EDT","volume":4177,"amount":1035456.53783,"timestamp":1786454999077,"change":0.08,"changeRate":0.000323,"amplitude":0.017655},"postHourTrading":{"tag":"盘后","latestPrice":250,"preClose":250.09,"latestTime":"19:37 EDT","volume":220292,"amount":55092700.71356,"timestamp":1786491428582,"change":-0.09,"changeRate":-0.00036,"amplitude":0.005118},"volumeRatio":0.832693,"impliedVol":0.2611,"impliedVolPercentile":0.2908},"requestUrl":"/m/hq/s/ABBV","defaultTab":"news","newsList":[{"id":"2656597285","title":"艾伯维（ABBV）保妥适新适应症获FDA受理 有望成美国首款咬肌突出医美肉毒制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2656597285","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656597285?lang=zh_cn&edition=full","pubTime":"2026-08-04 21:03","pubTimestamp":1785848630,"startTime":"0","endTime":"0","summary":"艾伯维表示，本次申报是对成熟产品潜力的进一步挖掘，以此匹配不断变化的求美者需求。作为医美赛道重磅单品，新适应症如若获批，有望进一步巩固艾尔建美学在注射医美领域的市场地位。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/NmRmY2E4Njg2ODIwNjk0NjU5Mw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NmRmY2E4Njg2ODIwNjk0NjU5Mw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"303400","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089283258.USD","VHT","IE00B3PB1722.GBP","PPH","SG9999015952.SGD","XLV","LU0942090050.USD","LU0820561818.USD","LU0965509101.SGD","JDOC","IE000MB6IJN5.SGD","PJP","IE000BZT7R73.USD","LU0158827948.USD","LABU","LU0795875169.SGD","LU0868494708.USD","TRUH","LU0912757837.SGD","LU2433249047.HKD","LU2125909593.SGD","IE000SO60NU8.SGD","LU1989771016.USD","FTXH","LU1670628061.USD","IE00B2B36J28.USD","LU1496350502.SGD","LU2129689605.HKD","LU0708994859.HKD","ABBV","FHLC","GLAM","IXJ","RXL","LU0965509010.AUD","SG9999015945.SGD","LU1670627923.USD","LU0738911758.USD","LU0553294199.USD","LU0289739699.SGD","IYH","MEDX","LU2129689431.USD","AGNG","LU1430594728.SGD","LU0320765646.SGD","LU1989772840.SGD","LU1989772923.USD","BK4588","LU0098860793.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175108203","title":"艾伯维三期临床研究达标：主要终点相较安慰剂实现统计学显著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1175108203","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175108203?lang=zh_cn&edition=full","pubTime":"2026-08-04 20:04","pubTimestamp":1785845057,"startTime":"0","endTime":"0","summary":"艾伯维公司（AbbVie）宣布，其三期临床研究成功达成主要终点，与安慰剂相比，展现出统计学意义上的显著改善。这一结果标志着该药物研发进程中的关键里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689431.USD","LU0417517546.SGD","IE00B19Z3B42.SGD","LU2129689605.HKD","LU2237443382.USD","LU2089283258.USD","LU0158827948.USD","LU1037948541.HKD","BK4550","LU1983299246.USD","LU2347655073.USD","LU1430594728.SGD","LU0912757837.SGD","LU0203347892.USD","PJP","LU0098860793.USD","LU0234570918.USD","LU0545039389.USD","LU0553294199.USD","LU0689472784.USD","XLV","LU0057025933.USD","BK4533","LU0943347566.SGD","LU0234572021.USD","LU1057294990.SGD","LU0965509010.AUD","LU0029864427.USD","LU0170899867.USD","LU0203345920.USD","LU0310799852.SGD","LU0795875086.SGD","BK4534","SG9999015978.USD","LU1934455194.USD","BK4559","LU2237443895.HKD","LU1934455863.HKD","LU0320765646.SGD","IE00B19Z3581.USD","IE00B2B36J28.USD","IE0004445239.USD","LU1670627923.USD","IE00BSNM7G36.USD","LU0738911758.USD","BK4585","LU1093756168.USD","LU0289739343.SGD","LU2237443622.USD","AGNG","LU0726765562.USD","LU1023059063.AUD","LU1267930573.SGD","LU0661504455.SGD","IE00B4R5TH58.HKD","LU0820561909.HKD","LU0511384066.AUD","LU0861579265.USD","PPH","LU1037948897.HKD","IE00BBT3K403.USD","SG9999001440.SGD","LU2125909593.SGD","LU1670628061.USD","IE000F7OJYX1.SGD","LU1989772923.USD","BK4581","IE000MB6IJN5.SGD","IE00BJT1NW94.SGD","LU1291159041.SGD","LU0859254822.USD","LU0985320562.USD","GLAM","SG9999015986.USD","LU0289739699.SGD","IE000SO60NU8.SGD","LU0198837287.USD","LU0289961442.SGD","IE00BVYPNW00.USD","IXJ","LU1551013342.USD","IE00BLSP4452.SGD","LU0124676726.USD","LU0058720904.USD","ABBV","FTXH","LU0965509283.SGD","LU1162221912.USD","LU1244550221.USD","LU2129689514.USD","LU1839511570.USD","LU1934455277.USD","LU0310800379.SGD","LU2237443465.HKD","LU1732799900.SGD","IE00BLSP4239.USD","LU1003077747.HKD","BK4588","LU1551013425.SGD","LU2237443978.SGD","IE0002270589.USD","LU0823416689.USD","LU2347655156.SGD","LU0795875169.SGD","LU1732800096.USD","LU1923622614.USD","LU0868494617.USD","SG9999015945.SGD","LU0942090050.USD","IE00BJJMRZ35.SGD","IE00BN8TJ469.HKD","LU0456855351.SGD","LU0211328371.USD","LU2089284900.SGD","LU2468319806.SGD","LU1074936037.SGD","LU0114720955.EUR","LU2023251221.USD","RXL","IE0009355771.USD","LU1496350171.SGD","LU0395794307.EUR","LU0069063385.USD","LU1093756325.SGD","IE00B42XCP33.USD","IE00BGHQF631.EUR","BK4139","IE000BZT7R73.USD","IE00BFTCPJ56.SGD","IE000WAW04H5.SGD","LU0708994859.HKD","LU0211327993.USD","LU0820561818.USD","SG9999011175.SGD","LU2433249047.HKD","LU0689626769.HKD","LU0868494708.USD","LU0882574055.USD","IE00B3PB1722.GBP","LU0965508806.USD","LU1244550494.USD","JDOC","LU0256863902.USD","LU1585245621.USD","LU0432979614.USD","LU2125909247.SGD","IE00BVYPNV92.GBP","LU1989772840.SGD","IE0000B7K699.USD","LU1718418525.SGD","IE0002141913.USD","IE00BDGV0183.EUR","LU2089984988.USD","LU2133065610.SGD","LU1061106388.HKD","LU1929549753.HKD","MEDX","LU0256863811.USD","VHT","LU1496350502.SGD","LU2112291526.USD","TRUH","IYH","LU2237443549.SGD","LU0949170772.SGD","BK4566","SG9999015952.SGD","LU0122379950.USD","LU1267930490.SGD","LU0128525929.USD","SG9999003800.SGD","LU1244550577.SGD","LU0472753341.HKD","FHLC","LU0965509101.SGD","LU1989771016.USD","LU2357627491.SGD","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173570619","title":"艾伯维旗下艾尔建美学宣布：保妥适®美容（用于咬肌突出）补充生物制剂许可申请获美国FDA受理","url":"https://stock-news.laohu8.com/highlight/detail?id=1173570619","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173570619?lang=zh_cn&edition=full","pubTime":"2026-08-04 20:02","pubTimestamp":1785844948,"startTime":"0","endTime":"0","summary":"艾伯维（AbbVie）旗下艾尔建美学（Allergan Aesthetics）今日正式对外宣告，其针对保妥适®美容（Botox® Cosmetic）用于改善咬肌突出问题的补充生物制剂许可申请（sBLA），已成功获得美国食品药品监督管理局（FDA）的受理。这一进展标志着该产品在拓展适应症领域迈出了关键一步，有望为相关需求人群提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772840.SGD","LU2089984988.USD","LU0289961442.SGD","LU1989772923.USD","SG9999015945.SGD","LU0965508806.USD","LU0256863811.USD","LU1037948897.HKD","LU1267930490.SGD","SG9999001440.SGD","BK4533","BK4585","IE00BLSP4452.SGD","IE0002141913.USD","LU0859254822.USD","LU1839511570.USD","LU0432979614.USD","LU2129689605.HKD","IE000BZT7R73.USD","LU0708994859.HKD","AGNG","LU2087621335.USD","LU0943347566.SGD","LU1934455194.USD","BK4139","LU1670628061.USD","LU1732800096.USD","LU0098860793.USD","BK4534","LU0689472784.USD","GLAM","LU2357627491.SGD","LU1496350502.SGD","LU2129689431.USD","IE00BBT3K403.USD","LU0949170772.SGD","LU1551013425.SGD","LU2112291526.USD","IE00B19Z3581.USD","LU0114720955.EUR","LU0912757837.SGD","LU0234570918.USD","IE00B3PB1722.GBP","LU1003077747.HKD","LU0122379950.USD","IE0000B7K699.USD","LU0545039389.USD","LU1732799900.SGD","PJP","LU0868494617.USD","LU0823416689.USD","IE0002270589.USD","LU0310800379.SGD","LU1244550577.SGD","LU1983299246.USD","LU1551013342.USD","LU0689626769.HKD","IE0009355771.USD","LU1934455277.USD","IE00BDGV0183.EUR","LU0211327993.USD","IYH","LU1061106388.HKD","IE0004445239.USD","LU0128525929.USD","LU1989771016.USD","LU0203345920.USD","LU2237443622.USD","IE000SO60NU8.SGD","LU1093756325.SGD","LU0289739343.SGD","LU1093756168.USD","LU0069063385.USD","LU0289739699.SGD","LU0861579265.USD","LU0198837287.USD","LU1074936037.SGD","SG9999015986.USD","LU0965509101.SGD","IE00BGHQF631.EUR","LU2237443465.HKD","IE00B19Z3B42.SGD","FHLC","LU0456855351.SGD","VHT","LU0170899867.USD","RXL","LU0726765562.USD","LU0058720904.USD","IE00BN8TJ469.HKD","LU2347655073.USD","SG9999015952.SGD","LU0472753341.HKD","JDOC","LU1430594728.SGD","LU0882574055.USD","LU2089284900.SGD","LU1496350171.SGD","LU1037948541.HKD","LU0553294199.USD","IE000MB6IJN5.SGD","IE000F7OJYX1.SGD","LU2023251221.USD","BK4550","LU0820561909.HKD","LU0234572021.USD","LU1929549753.HKD","LU0511384066.AUD","MEDX","ABBV","BK4566","LU2468319806.SGD","LU0661504455.SGD","FTXH","LU0985320562.USD","LU1162221912.USD","SG9999011175.SGD","LU0158827948.USD","LU0211328371.USD","PPH","XLV","IE00B4R5TH58.HKD","LU1244550494.USD","LU2129689514.USD","LU2089283258.USD","IE00BVYPNV92.GBP","LU2125909247.SGD","IE00B42XCP33.USD","LU1057294990.SGD","IXJ","LU0256863902.USD","BK4581","IE000WAW04H5.SGD","LU2237443549.SGD","IE00BJT1NW94.SGD","LU1923622614.USD","LU2237443895.HKD","SG9999015978.USD","LU0965509010.AUD","LU1291159041.SGD","BK4559","IE00BLSP4239.USD","LU2237443978.SGD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0310799852.SGD","LU0795875169.SGD","LU1023059063.AUD","LU2133065610.SGD","IE00BJJMRZ35.SGD","LU1244550221.USD","LU0203347892.USD","LU0417517546.SGD","LU0124676726.USD","LU1267930573.SGD","LU1718418525.SGD","LU0965509283.SGD","SG9999003800.SGD","LU0738911758.USD","IE00BSNM7G36.USD","LU0320765646.SGD","TRUH","LU1585245621.USD","LU0795875086.SGD","LU0057025933.USD","LU2125909593.SGD","LU1670627923.USD","LU0395794307.EUR","IE00BVYPNW00.USD","LU1934455863.HKD","BK4588","LU0029864427.USD","LU2433249047.HKD","LU2347655156.SGD","LU0820561818.USD","LU2237443382.USD","LU0942090050.USD","LU0868494708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107633372","title":"异动解读｜艾伯维公司盘中下跌3.04%，Q2业绩超预期但全年盈利指引因收购摊薄下调","url":"https://stock-news.laohu8.com/highlight/detail?id=1107633372","media":"行情直击","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107633372?lang=zh_cn&edition=full","pubTime":"2026-07-31 22:04","pubTimestamp":1785506697,"startTime":"0","endTime":"0","summary":"7月31日，艾伯维公司盘中下跌3.04%，报251.87美元/股，成交额3.18亿美元。然而，公司将全年调整后每股收益指引下调至13.87至14.07美元，低于此前的13.91至14.11美元，亦低于市场预期的14.06美元。指引下调主要源于收购Apogee Therapeutics带来的每股约0.14美元摊薄影响，以及第二季度计入的2.91亿美元IPR&D费用对每股收益造成的0.17美元拖累。业绩兑现后，市场对全年盈利前景的担忧触发获利回吐。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154857507","title":"艾伯维Q2业绩超预期，Skyrizi与Rinvoq表现亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=1154857507","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154857507?lang=zh_cn&edition=full","pubTime":"2026-07-31 21:37","pubTimestamp":1785505047,"startTime":"0","endTime":"0","summary":"摩根大通分析师在最新研究报告中指出，艾伯维公司第二季度财报业绩超出市场预期。营收超预期表现颇为广泛——其中，Skyrizi和Rinvoq这两款药物的销售数据均小幅超过预估。分析师补充道：\"在接下来的业绩电话会上，我们将密切关注两大核心议题：其一，Skyrizi和Rinvoq的市场渗透率是否出现变化，以及针对这两款药物的最新业绩指引；其二，关于业务拓展方面的战略表态。\"值得注意的是，艾伯维在早盘交易中下跌1%。此前，该公司下调了全年调整后盈利预期，主要归因于其对Apogee Therapeutics的收购交易。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXL","LU2129689431.USD","IE00BLSP4239.USD","LU1732799900.SGD","LU1244550494.USD","LU2433249047.HKD","SG9999011175.SGD","IE00B3PB1722.GBP","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE00BDGV0183.EUR","LU1003077747.HKD","LU0472753341.HKD","LU0795875086.SGD","BK4585","LU2112291526.USD","LU0114720955.EUR","LU1093756325.SGD","LU2023251221.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00BVYPNW00.USD","LU0511384066.AUD","IE00B19Z3B42.SGD","GLAM","IE0004445239.USD","LU0820561818.USD","IE00BBT3K403.USD","LU0965509010.AUD","BK4550","FTXH","LU0417517546.SGD","SG9999001440.SGD","BK4534","LU2087621335.USD","LU1023059063.AUD","LU1074936037.SGD","IE00B19Z3581.USD","LU0098860793.USD","LU1291159041.SGD","IE000WAW04H5.SGD","LU0820561909.HKD","LU0170899867.USD","LU2468319806.SGD","LU1551013425.SGD","LU0726765562.USD","IYH","LU0965509101.SGD","LU2237443465.HKD","LU0289739343.SGD","LU2347655156.SGD","PJP","LU1162221912.USD","LU1093756168.USD","LU2089984988.USD","LU2125909593.SGD","LU1037948541.HKD","LU1934455194.USD","LU0234572021.USD","LU1670628061.USD","LU0122379950.USD","LU0545039389.USD","LU1670627923.USD","LU0069063385.USD","IE000SO60NU8.SGD","AGNG","LU1839511570.USD","LU2133065610.SGD","LU0949170772.SGD","LU1989772840.SGD","LU2089284900.SGD","LU0289961442.SGD","LU0912757837.SGD","LU0985320562.USD","LU0128525929.USD","FHLC","LU0256863902.USD","LU1934455863.HKD","LU0942090050.USD","SG9999003800.SGD","LU0823416689.USD","BK4581","BK4139","IE00BVYPNV92.GBP","LU2237443382.USD","LU0795875169.SGD","LU0861579265.USD","LU2357627491.SGD","LU0234570918.USD","SG9999015945.SGD","LU1496350502.SGD","LU1244550577.SGD","IXJ","LU1929549753.HKD","IE00B4R5TH58.HKD","LU0203345920.USD","IE00B42XCP33.USD","LU0256863811.USD","LU0965509283.SGD","ABBV","BK4566","LU0158827948.USD","LU1551013342.USD","SG9999015952.SGD","LU0689472784.USD","LU1496350171.SGD","LU0708994859.HKD","LU0029864427.USD","LU0456855351.SGD","LU2129689605.HKD","BK4559","LU0432979614.USD","LU0965508806.USD","LU1037948897.HKD","BK4588","IE00BN8TJ469.HKD","LU0868494617.USD","IE0000B7K699.USD","LU1989771016.USD","LU2347655073.USD","IE0002141913.USD","LU0882574055.USD","LU1244550221.USD","LU2237443978.SGD","BK4533","LU0198837287.USD","LU1923622614.USD","LU0738911758.USD","XLV","LU1061106388.HKD","IE000F7OJYX1.SGD","LU0058720904.USD","IE00BSNM7G36.USD","LU0211327993.USD","IE000MB6IJN5.SGD","LU0320765646.SGD","LU0689626769.HKD","LU1585245621.USD","LU1983299246.USD","LU1732800096.USD","IE0002270589.USD","LU0203347892.USD","PPH","LU1057294990.SGD","IE00BGHQF631.EUR","IE00BLSP4452.SGD","LU0553294199.USD","LU0395794307.EUR","LU1430594728.SGD","LU0289739699.SGD","LU0859254822.USD","IE000BZT7R73.USD","LU0661504455.SGD","LU1718418525.SGD","LU0943347566.SGD","LU0310800379.SGD","LU1989772923.USD","LU2237443622.USD","LU1267930490.SGD","LU2125909247.SGD","MEDX","VHT","LU0057025933.USD","LU0310799852.SGD","LU2129689514.USD","IE00BJJMRZ35.SGD","LU0868494708.USD","LU2237443549.SGD","LU1267930573.SGD","SG9999015986.USD","LU0211328371.USD","TRUH","LU0124676726.USD","LU2237443895.HKD","SG9999015978.USD","LU2089283258.USD","JDOC","LU1934455277.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127614771","title":"艾伯维高管透露：第三季度调整后每股收益预计在3.84至3.88美元之间","url":"https://stock-news.laohu8.com/highlight/detail?id=1127614771","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127614771?lang=zh_cn&edition=full","pubTime":"2026-07-31 21:34","pubTimestamp":1785504866,"startTime":"0","endTime":"0","summary":"艾伯维公司高管在电话会议中表示，预计第三季度调整后每股收益将在3.84至3.88美元之间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0912757837.SGD","LU2089284900.SGD","LU0122379950.USD","IE00BGHQF631.EUR","LU0868494708.USD","LU0289739343.SGD","LU1989771016.USD","LU0058720904.USD","XLV","LU0689472784.USD","LU1037948897.HKD","LU1934455277.USD","LU2237443382.USD","LU2237443895.HKD","LU0823416689.USD","SG9999015986.USD","LU0511384066.AUD","LU2125909247.SGD","BK4588","LU2023251221.USD","LU2089984988.USD","IE000F7OJYX1.SGD","ABBV","LU0553294199.USD","LU1093756325.SGD","LU1267930573.SGD","LU2089283258.USD","IE000WAW04H5.SGD","IE00BDGV0183.EUR","IE00BN8TJ469.HKD","LU0203345920.USD","LU1162221912.USD","LU1585245621.USD","LU2237443465.HKD","LU0057025933.USD","LU1244550577.SGD","TRUH","IE0002270589.USD","LU0029864427.USD","LU1732799900.SGD","LU2125909593.SGD","MEDX","BK4559","LU0432979614.USD","IE00B19Z3B42.SGD","LU2347655073.USD","LU1670628061.USD","LU0820561909.HKD","IE0002141913.USD","LU0859254822.USD","LU2129689514.USD","SG9999015945.SGD","LU0949170772.SGD","LU0310800379.SGD","LU2237443549.SGD","LU0289961442.SGD","IE00BLSP4239.USD","LU2133065610.SGD","LU2237443978.SGD","IE00B2B36J28.USD","IE0000B7K699.USD","LU0661504455.SGD","LU0965509283.SGD","IE00BJT1NW94.SGD","LU0943347566.SGD","FTXH","LU1074936037.SGD","LU1496350502.SGD","LU0965509101.SGD","LU1718418525.SGD","IE00BSNM7G36.USD","LU0417517546.SGD","LU0861579265.USD","PJP","LU1839511570.USD","LU0170899867.USD","LU0203347892.USD","LU1093756168.USD","BK4534","LU0395794307.EUR","LU1732800096.USD","LU0942090050.USD","FHLC","GLAM","RXL","LU1989772923.USD","LU0795875169.SGD","LU0211327993.USD","BK4566","JDOC","LU0234570918.USD","IE000MB6IJN5.SGD","LU1023059063.AUD","LU0114720955.EUR","LU1496350171.SGD","IE00BJJMRZ35.SGD","IE00B3PB1722.GBP","LU1670627923.USD","LU0098860793.USD","SG9999001440.SGD","IE000BZT7R73.USD","IE00BVYPNV92.GBP","IYH","LU0069063385.USD","LU1934455863.HKD","LU0882574055.USD","LU0985320562.USD","LU0124676726.USD","LU1551013425.SGD","LU1003077747.HKD","LU2347655156.SGD","IE00B19Z3581.USD","LU1929549753.HKD","BK4585","LU0320765646.SGD","LU1061106388.HKD","LU1934455194.USD","SG9999015978.USD","LU0158827948.USD","LU0726765562.USD","LU0310799852.SGD","LU0545039389.USD","LU0198837287.USD","SG9999011175.SGD","LU0289739699.SGD","LU0965509010.AUD","IE00BLSP4452.SGD","LU1983299246.USD","IE00BBT3K403.USD","LU0128525929.USD","BK4139","AGNG","LU0795875086.SGD","LU0211328371.USD","LU2129689605.HKD","LU1989772840.SGD","BK4581","LU1923622614.USD","LU0472753341.HKD","LU1291159041.SGD","BK4533","LU2087621335.USD","IXJ","LU1057294990.SGD","LU2112291526.USD","LU0738911758.USD","LU2468319806.SGD","IE0009355771.USD","LU0256863811.USD","IE000SO60NU8.SGD","LU2357627491.SGD","SG9999003800.SGD","LU1267930490.SGD","SG9999015952.SGD","BK4550","LU1551013342.USD","LU0456855351.SGD","LU2237443622.USD","IE00BFTCPJ56.SGD","LU0965508806.USD","LU2129689431.USD","LU0868494617.USD","LU1037948541.HKD","LU2433249047.HKD","IE00BVYPNW00.USD","LU0256863902.USD","VHT","LU0708994859.HKD","LU0689626769.HKD","IE00B42XCP33.USD","LU1430594728.SGD","IE00B4R5TH58.HKD","LU1244550494.USD","PPH","LU0234572021.USD","LU0820561818.USD","IE0004445239.USD","LU1244550221.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161700508","title":"艾伯维高管透露：全年净营收预期上调至约676亿美元，较此前预测增加3亿美元——电话会议实录","url":"https://stock-news.laohu8.com/highlight/detail?id=1161700508","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161700508?lang=zh_cn&edition=full","pubTime":"2026-07-31 21:28","pubTimestamp":1785504492,"startTime":"0","endTime":"0","summary":"艾伯维公司高管在电话会议中表示，目前预计全年总净营收将达到约676亿美元。这一数字相较于此前预测，上调了整整3亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","LU1585245621.USD","LU0211328371.USD","LU0069063385.USD","SG9999011175.SGD","IE00B3PB1722.GBP","LU0726765562.USD","LU0949170772.SGD","BK4550","BK4581","LU0320765646.SGD","LU0289961442.SGD","FHLC","SG9999015945.SGD","LU2468319806.SGD","IE00BJT1NW94.SGD","TRUH","IE000F7OJYX1.SGD","LU1551013342.USD","PPH","LU0820561909.HKD","BK4588","LU0795875086.SGD","IE00BDGV0183.EUR","LU0029864427.USD","BK4566","LU1074936037.SGD","LU1430594728.SGD","LU0124676726.USD","LU0417517546.SGD","IE000BZT7R73.USD","LU0310800379.SGD","LU1934455194.USD","LU2237443382.USD","LU0661504455.SGD","LU0861579265.USD","LU0211327993.USD","IE00B19Z3B42.SGD","LU0472753341.HKD","LU1989771016.USD","AGNG","LU1496350171.SGD","IYH","SG9999001440.SGD","VHT","FTXH","SG9999015986.USD","LU1267930573.SGD","LU1023059063.AUD","LU2112291526.USD","LU0256863902.USD","LU2089283258.USD","LU0432979614.USD","LU1291159041.SGD","IE0009355771.USD","LU1267930490.SGD","LU0942090050.USD","LU1923622614.USD","LU0859254822.USD","SG9999003800.SGD","IE00BVYPNV92.GBP","BK4585","LU1057294990.SGD","LU0122379950.USD","LU2129689605.HKD","IE00BN8TJ469.HKD","LU1093756168.USD","LU2237443465.HKD","LU1670627923.USD","LU0965509283.SGD","LU1244550494.USD","IE00BFTCPJ56.SGD","LU2237443895.HKD","LU0289739343.SGD","LU1670628061.USD","LU0511384066.AUD","ABBV","LU0708994859.HKD","LU1983299246.USD","LU2089984988.USD","LU2237443549.SGD","LU0545039389.USD","IE00BGHQF631.EUR","LU1989772840.SGD","SG9999015952.SGD","LU0395794307.EUR","LU0985320562.USD","LU0882574055.USD","LU0289739699.SGD","LU1934455277.USD","LU2129689431.USD","IE0002270589.USD","LU1244550577.SGD","IE00B42XCP33.USD","BK4139","LU0310799852.SGD","LU0868494617.USD","LU1934455863.HKD","LU1162221912.USD","IE00BSNM7G36.USD","IE00B4R5TH58.HKD","LU2433249047.HKD","IE000SO60NU8.SGD","LU0823416689.USD","XLV","LU0058720904.USD","LU2237443622.USD","LU0965508806.USD","LU1732800096.USD","LU0456855351.SGD","BK4559","LU0689626769.HKD","IE0004445239.USD","LU0098860793.USD","LU0256863811.USD","LU0203345920.USD","IE00BVYPNW00.USD","LU0965509101.SGD","LU0965509010.AUD","LU2125909247.SGD","IE00BBT3K403.USD","LU0795875169.SGD","LU0198837287.USD","LU1037948897.HKD","LU1061106388.HKD","LU0553294199.USD","LU1718418525.SGD","LU2125909593.SGD","LU2089284900.SGD","LU2129689514.USD","LU2133065610.SGD","LU0170899867.USD","LU0203347892.USD","LU1929549753.HKD","LU2347655156.SGD","LU2237443978.SGD","LU0689472784.USD","GLAM","LU0158827948.USD","LU1093756325.SGD","LU1244550221.USD","RXL","BK4533","LU1732799900.SGD","LU0868494708.USD","MEDX","IE000WAW04H5.SGD","LU2023251221.USD","LU1839511570.USD","LU2347655073.USD","LU2087621335.USD","LU0128525929.USD","BK4534","LU0114720955.EUR","IE0002141913.USD","LU1003077747.HKD","LU2357627491.SGD","PJP","LU1551013425.SGD","IE0000B7K699.USD","LU0234572021.USD","JDOC","LU0820561818.USD","LU0943347566.SGD","IE00B19Z3581.USD","IE00BJJMRZ35.SGD","SG9999015978.USD","IE000MB6IJN5.SGD","LU1037948541.HKD","LU0738911758.USD","IXJ","LU1989772923.USD","LU0912757837.SGD","LU0234570918.USD","LU1496350502.SGD","LU0057025933.USD","IE00B2B36J28.USD","IE00BLSP4452.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177080903","title":"盘前异动 | 艾伯维公司盘前跌近4%，Q2业绩超预期，全年EPS指引低于市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1177080903","media":"老虎资讯综合","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177080903?lang=zh_cn&edition=full","pubTime":"2026-07-31 20:18","pubTimestamp":1785500326,"startTime":"0","endTime":"0","summary":"7月31日，艾伯维公司盘前跌近4%，报247.52美元。消息面上，艾伯维公布2026年第二季度财报，业绩整体超过市场预期。公司季度调整后每股收益为3.65美元，同比增长，超过分析师预期的3.60美元；净营收达到169.9亿美元，同比增长，高于市场预期的167.8亿美元。","market":"us","thumbnail":"https://community-static.tradeup.com/news/6bb866e880ad7b7bfe6294488235517c","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/6bb866e880ad7b7bfe6294488235517c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"盘前异动 | 艾伯维公司盘前跌近4%，Q2业绩超预期，全年EPS指引低于市场预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120758809","title":"异动解读｜艾伯维公司盘前下跌4.29%，Q2业绩超预期但收购摊薄压制全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1120758809","media":"行情直击","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120758809?lang=zh_cn&edition=full","pubTime":"2026-07-31 19:53","pubTimestamp":1785498788,"startTime":"0","endTime":"0","summary":"7月31日，艾伯维公司盘前下跌4.29%，报250.0美元/股，成交额202.1万美元。消息面上，公司发布第二季度财报，调整后每股收益3.65美元，超市场预期的3.60美元；营收169.90亿美元，超预期的167.65亿美元，同比增幅显著。此前公司股价在多重利好推动下已累计大幅上涨，巴克莱等多家机构上调目标价，市场对财报预期充分定价，业绩兑现后获利回吐压力明显。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158299319","title":"艾伯维：2026财年调整后每股收益指引包含收购Apogee Therapeutics带来的每股0.14美元摊薄影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1158299319","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158299319?lang=zh_cn&edition=full","pubTime":"2026-07-31 19:48","pubTimestamp":1785498494,"startTime":"0","endTime":"0","summary":"艾伯维公司（AbbVie）近日披露，其2026财年调整后的每股收益（EPS）指引中，已纳入了因收购Apogee Therapeutics而产生的每股约0.14美元的摊薄效应。这一财务影响，直接在预期利润数据中体现，显示出公司对近期并购交易成本进行的前瞻性评估。通过此次收购，艾伯维正积极推进其战略布局，但短期内，该交易将对每股收益构成一定压力。市场分析师正密切关注这一指引，以评估其对公司未来盈利能力的潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494708.USD","XLV","LU0661504455.SGD","LU2129689431.USD","SG9999015978.USD","LU2347655156.SGD","LU0098860793.USD","LU1074936037.SGD","LU0823416689.USD","LU0820561909.HKD","LU1093756325.SGD","LU1551013425.SGD","LU1934455194.USD","LU2433249047.HKD","BK4534","LU0256863902.USD","LU0985320562.USD","IE00BVYPNW00.USD","LU0795875169.SGD","LU2468319806.SGD","LU2237443465.HKD","LU0861579265.USD","BK4566","IE00B2B36J28.USD","LU0965509101.SGD","LU1244550221.USD","LU1291159041.SGD","LU2112291526.USD","IE00B4R5TH58.HKD","LU1162221912.USD","LU0859254822.USD","LU0689626769.HKD","LU0432979614.USD","LU1718418525.SGD","LU1244550494.USD","LU0289739699.SGD","LU1934455277.USD","LU2133065610.SGD","TRUH","IE000MB6IJN5.SGD","LU2237443895.HKD","IE00B19Z3581.USD","LU1496350502.SGD","LU0320765646.SGD","ABBV","LU2023251221.USD","GLAM","LU0234572021.USD","SG9999001440.SGD","LU0170899867.USD","IE00BDGV0183.EUR","LU0158827948.USD","LU0114720955.EUR","IE000WAW04H5.SGD","LU2089283258.USD","LU0289739343.SGD","LU1989772923.USD","LU0949170772.SGD","LU0124676726.USD","PJP","IE000SO60NU8.SGD","LU2237443622.USD","LU0198837287.USD","IE00BLSP4452.SGD","LU2089984988.USD","LU2237443382.USD","IE00BSNM7G36.USD","LU1037948541.HKD","LU1732800096.USD","LU1551013342.USD","IYH","LU1267930573.SGD","LU2237443978.SGD","LU1732799900.SGD","BK4533","LU2089284900.SGD","LU0211327993.USD","BK4559","LU0289961442.SGD","PPH","LU1934455863.HKD","LU1037948897.HKD","BK4585","LU0203347892.USD","LU0234570918.USD","IXJ","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU2357627491.SGD","SG9999015945.SGD","LU0689472784.USD","LU0256863811.USD","SG9999015986.USD","LU0943347566.SGD","LU2129689605.HKD","LU0545039389.USD","SG9999003800.SGD","LU2347655073.USD","IE0002270589.USD","LU2125909593.SGD","LU0965508806.USD","IE00BBT3K403.USD","RXL","LU1057294990.SGD","LU0868494617.USD","LU1496350171.SGD","LU0058720904.USD","LU1061106388.HKD","IE00BLSP4239.USD","LU0820561818.USD","IE00BN8TJ469.HKD","LU0882574055.USD","IE0000B7K699.USD","MEDX","IE00BVYPNV92.GBP","LU2129689514.USD","LU0472753341.HKD","LU0912757837.SGD","LU1989772840.SGD","IE00B42XCP33.USD","LU1839511570.USD","IE00B3PB1722.GBP","LU0310799852.SGD","FTXH","LU1267930490.SGD","FHLC","LU0942090050.USD","IE00B19Z3B42.SGD","LU1983299246.USD","LU0553294199.USD","LU0211328371.USD","BK4581","LU2087621335.USD","IE000F7OJYX1.SGD","JDOC","IE0002141913.USD","LU2237443549.SGD","LU0310800379.SGD","BK4550","IE00BJT1NW94.SGD","LU1929549753.HKD","AGNG","LU0738911758.USD","LU0395794307.EUR","VHT","LU1003077747.HKD","LU0128525929.USD","LU1430594728.SGD","BK4139","IE00BGHQF631.EUR","IE0009355771.USD","LU0069063385.USD","IE0004445239.USD","LU0122379950.USD","LU1670628061.USD","LU1244550577.SGD","LU0708994859.HKD","LU0726765562.USD","LU1585245621.USD","LU0456855351.SGD","LU0417517546.SGD","IE00BJJMRZ35.SGD","LU2125909247.SGD","LU0203345920.USD","LU1923622614.USD","SG9999015952.SGD","LU0795875086.SGD","LU0029864427.USD","LU1670627923.USD","LU0965509283.SGD","LU1093756168.USD","LU1989771016.USD","SG9999011175.SGD","BK4588","LU0511384066.AUD","IE000BZT7R73.USD","LU0057025933.USD","LU0965509010.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191974640","title":"艾伯维公司：第二季度业绩受收购IPR&D及里程碑费用影响，每股收益减少0.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191974640","media":"美股速递","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191974640?lang=zh_cn&edition=full","pubTime":"2026-07-31 19:48","pubTimestamp":1785498491,"startTime":"0","endTime":"0","summary":"艾伯维公司（AbbVie）公布的第二季度财报显示，因收购过程中的在研项目（IPR&D）及里程碑费用支出，其每股收益遭遇了0.17美元的不利冲击。这一财务指标的下滑，主要源于相关并购活动产生的成本摊销。具体来看，这些费用直接拖累了公司本季度的盈利表现，使得每股收益数据承压。尽管面临此类短期财务挑战，但公司整体运营仍保持稳健。市场分析人士指出，此类一次性支出虽会影响短期业绩，但却是公司长期战略布局中不可或缺的一部分，旨在通过外部研发合作和里程碑式进展来巩固未来增长潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550494.USD","BK4533","BK4585","LU1291159041.SGD","LU0158827948.USD","LU1093756325.SGD","IYH","SG9999015986.USD","IE00B2B36J28.USD","LU2237443382.USD","LU1003077747.HKD","FTXH","IE00BGHQF631.EUR","LU1585245621.USD","LU0098860793.USD","LU1934455277.USD","LU2237443978.SGD","LU2089284900.SGD","LU0661504455.SGD","LU2347655156.SGD","LU0289739343.SGD","IE00BLSP4239.USD","LU0795875169.SGD","LU0823416689.USD","IE00B19Z3581.USD","IE00BBT3K403.USD","LU2237443622.USD","LU0310800379.SGD","LU2237443895.HKD","LU2347655073.USD","LU0708994859.HKD","LU2087621335.USD","IE00B4R5TH58.HKD","LU0029864427.USD","LU0057025933.USD","LU0170899867.USD","LU0211327993.USD","IE00B3PB1722.GBP","TRUH","LU1718418525.SGD","LU0965508806.USD","LU0949170772.SGD","LU0820561909.HKD","IE000BZT7R73.USD","LU2133065610.SGD","LU0211328371.USD","LU0256863811.USD","LU1057294990.SGD","LU2237443465.HKD","BK4581","LU0965509101.SGD","LU0310799852.SGD","LU1934455194.USD","LU1732800096.USD","BK4566","PJP","LU0128525929.USD","FHLC","LU0417517546.SGD","LU1267930573.SGD","LU0868494617.USD","LU0795875086.SGD","LU0868494708.USD","IE00B42XCP33.USD","LU1929549753.HKD","IE00BN8TJ469.HKD","BK4588","LU1923622614.USD","VHT","LU0738911758.USD","LU0912757837.SGD","IE0002141913.USD","IE00BVYPNV92.GBP","IXJ","LU1074936037.SGD","LU1983299246.USD","LU0985320562.USD","LU0203345920.USD","LU1551013425.SGD","LU0289739699.SGD","LU2237443549.SGD","GLAM","LU0234572021.USD","LU0256863902.USD","LU1732799900.SGD","ABBV","LU1670627923.USD","BK4534","IE00BVYPNW00.USD","LU2089984988.USD","LU1244550221.USD","LU0545039389.USD","LU0882574055.USD","LU2357627491.SGD","LU0456855351.SGD","LU0859254822.USD","LU1989771016.USD","IE0004445239.USD","LU1061106388.HKD","LU1670628061.USD","SG9999015945.SGD","LU0689472784.USD","LU0689626769.HKD","LU0965509283.SGD","LU2433249047.HKD","LU0124676726.USD","SG9999015952.SGD","IE00BDGV0183.EUR","PPH","LU1093756168.USD","LU2129689605.HKD","LU2129689431.USD","LU2125909247.SGD","BK4559","LU0553294199.USD","LU0058720904.USD","MEDX","SG9999003800.SGD","BK4139","LU0320765646.SGD","LU2129689514.USD","IE00BLSP4452.SGD","LU1496350502.SGD","LU1162221912.USD","SG9999001440.SGD","LU1551013342.USD","LU0289961442.SGD","IE000WAW04H5.SGD","LU0943347566.SGD","LU1989772840.SGD","LU0069063385.USD","IE0000B7K699.USD","LU2112291526.USD","IE00BJJMRZ35.SGD","LU1430594728.SGD","SG9999015978.USD","LU0965509010.AUD","LU1934455863.HKD","LU1267930490.SGD","LU0203347892.USD","IE0002270589.USD","IE000MB6IJN5.SGD","LU1037948897.HKD","IE0009355771.USD","LU0511384066.AUD","LU1023059063.AUD","LU1839511570.USD","LU2468319806.SGD","LU0395794307.EUR","LU2023251221.USD","IE00BSNM7G36.USD","IE000F7OJYX1.SGD","IE00B19Z3B42.SGD","LU0234570918.USD","LU0820561818.USD","AGNG","LU1244550577.SGD","LU1037948541.HKD","LU1989772923.USD","LU2125909593.SGD","LU2089283258.USD","XLV","LU0942090050.USD","IE00BJT1NW94.SGD","LU0432979614.USD","IE00BFTCPJ56.SGD","RXL","IE000SO60NU8.SGD","LU1496350171.SGD","LU0122379950.USD","LU0472753341.HKD","LU0726765562.USD","LU0198837287.USD","BK4550","LU0861579265.USD","SG9999011175.SGD","LU0114720955.EUR","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121244940","title":"异动解读｜艾伯维公司盘中下跌3.15%，生物科技板块普跌叠加财报发布前夕承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1121244940","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121244940?lang=zh_cn&edition=full","pubTime":"2026-07-30 22:57","pubTimestamp":1785423426,"startTime":"0","endTime":"0","summary":"7月30日，艾伯维公司盘中下跌3.15%，报255.805美元/股，成交额3.42亿美元。当日生物科技板块普遍走弱，行业内阿尔尼拉姆制药大跌逾26%，Madrigal跌超12%，吉利德科学跌超2%，安进跌近2%，板块抛压明显。公司将于7月31日发布第二季度财报，市场预期营收约167.60亿美元，同比增长11.54%，调整后每股收益3.57至3.61美元，同比增超24%。在连续利好推升股价后，财报发布前夕板块整体回调，公司股价随之承压。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117275596","title":"美股异动｜医药股板块普涨，葛兰素史克涨近7%，安进涨超5%，艾伯维公司涨近4%，辉瑞、默沙东涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117275596","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117275596?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:29","pubTimestamp":1785248946,"startTime":"0","endTime":"0","summary":"7月28日，医药股板块普涨，葛兰素史克涨近7%，安进涨超5%，艾伯维公司涨近4%，辉瑞、默沙东涨超3%，强生涨近3%，礼来涨超2%。消息面上，葛兰素史克公布的二季度财报显示，调整后每股收益为50.5便士，显著高于市场预期的46.8便士，盈利表现超出预期。与此同时，葛兰素史克宣布计划到2029年全面实现每年19亿英镑的成本节约，这一目标进一步增强了投资者对公司未来盈利能力的信心。","market":"us","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLYZ","GSKH","LLII","MRK","AMGN","JNJ","LLY","LLYX","PFE","GSK","ABBV","ELIS","ELIL"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1147706356","title":"异动解读｜艾伯维公司盘中上涨3.06%，巴克莱上调目标价至300美元叠加财报预期催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1147706356","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147706356?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:23","pubTimestamp":1785248635,"startTime":"0","endTime":"0","summary":"7月28日，艾伯维公司盘中上涨3.06%，报266.48美元/股，成交额2.75亿美元。消息面上，巴克莱当日将艾伯维目标价从275美元上调至300美元，维持\"跑赢大盘\"评级，为近期机构给出的最高目标价。此外，公司将于7月31日发布第二季度财报，市场预期营收约167.60亿美元，同比增长11.54%，调整后每股收益3.57至3.61美元，同比增长超24%。近期Epcoritamab联合疗法获欧盟批准、Boey获欧盟上市许可、109亿美元收购Apogee强化免疫学布局等多重利好叠加，推动投资者情绪偏暖。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654007935","title":"解读世界500强榜单医药板块：强生继续“霸榜”，礼来排名上升112位，3家中国企业入选","url":"https://stock-news.laohu8.com/highlight/detail?id=2654007935","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654007935?lang=zh_cn&edition=full","pubTime":"2026-07-28 20:51","pubTimestamp":1785243108,"startTime":"0","endTime":"0","summary":"7月28日，2026年《财富》世界500强榜单正式发布。《每日经济新闻》记者注意到，医疗健康板块作为全球五大支柱行业之一，共有31家企业上榜。其中，礼来公司排名从2025年的336位上升至今年的224位，成为今年上涨最快的10家公司之一。中国公司中，中国医药集团、上海医药、广药集团3家公司再次入围。《每日经济新闻》记者注意到，位居医疗健康相关企业榜首的是联合健康集团。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607283823749452.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607283823749452.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1066051225.USD","LU0980610538.SGD","IE00B19Z8W00.USD","IE00BFTCPJ56.SGD","LU0096364046.USD","LU0345769631.USD","LU0545039389.USD","LU1003077747.HKD","LU0211327993.USD","LU1043141123.HKD","LU2347655073.USD","PJP","LU1791710582.SGD","LU2430703251.USD","SGXZ99366536.SGD","LU2999663052.SGD","LU1935042991.SGD","LU0965509283.SGD","LU1974910355.USD","AMGN","LU1228905540.USD","LU2168564065.EUR","IE00BSNM7G36.USD","LU0708995401.HKD","IE00B42XCP33.USD","LU2087625088.SGD","LU2361044949.HKD","LU2596442595.SGD","LU1670627923.USD","IE00BN29S564.USD","IE00BBT3K403.USD","LU2461242641.AUD","IE00B7SZLL34.SGD","LU2125154778.USD","LU0354030438.USD","LU1037948897.HKD","UNHG","LU0203201768.USD","SG9999002232.USD","LU0234572021.USD","LU2552382058.USD","IE00B19Z3581.USD","LU2417539215.USD","LU0353189680.USD","BK4559","BK4581","LU0323591593.USD","LU2237443978.SGD","BBH","IE0009355771.USD","LU0868494708.USD","LU0640476718.USD","BK4550","LU1221951046.USD","LU2357627491.SGD","LU0417517546.SGD","LU1989772840.SGD","LU0553294199.USD","LU1116320737.USD","LLYX","IE00BN8TJ469.HKD","LU0208291251.USD","LU0310800379.SGD","LLYZ","SG9999014575.USD","LU1983299246.USD","LU1430594728.SGD","BK4007","LU2746668974.SGD","SG9999011175.SGD","IE00BFSS7M15.SGD","LU0823434583.USD","LU1035775433.USD","LU0943347566.SGD","LU2462591277.SGD","VHT","LU0320765992.SGD","SG9999001440.SGD","LU2462591350.SGD","LU1153585028.USD","LU0985320562.USD","LU2168563687.JPY","LU2347655156.SGD","IE00BVYPNW00.USD","LU0174119429.USD","LU0345770308.USD","LU1069347547.HKD","LU2028103732.USD","LU2471134952.CNY","LU2129689605.HKD","LU1261432733.SGD","BK4534","IHE","LU0672654240.SGD","LU1778281490.HKD","IBB","LU1674673428.USD","LU0289961442.SGD","LU0965509010.AUD","UNHW","LU2362541513.USD","ABBV","IE00B19Z3B42.SGD","BMED","LU0385154629.USD","LU0557290698.USD","LU0211328371.USD","LU1868836914.USD","LU2471134796.USD","IHF","LU2362540622.SGD","SG9999015952.SGD","IE00BLSP4239.USD","LU1941712264.USD","LU1854103824.USD","LU2023250843.SGD","LU2592432038.USD","LU0158827948.USD","PPH","LU1201861249.SGD","LU0256863902.USD","LU2133065610.SGD","MEDX","GB00BDT5M118.USD","LU0128525689.USD","LU1093756168.USD","LU0976567544.SGD","LU2552382215.SGD","LU1623119135.USD","AGNG","LU0310799852.SGD","LU1883839398.USD","LU1035773651.USD","LU1032955483.USD","LU0234570918.USD","LU2125909247.SGD","GLAM","ELIL","LU1934455277.USD","LU0225771236.USD","LU2237443549.SGD","LU1868837300.USD","LU0868494617.USD","SG9999001176.SGD","LU1280957306.USD","HRTS","LU0077335932.USD","LU1037948541.HKD","LU1023059063.AUD","LU1267930813.SGD","IE00B19Z9P08.USD","LU1804176565.USD","LU0528227936.USD","LU1988902786.USD","WDNA","LU1923622614.USD","IXJ","LU0122379950.USD","LU1718418525.SGD","IE00B3PB1722.GBP","NVOH","LU2360106947.USD","IE0034235303.USD","SG9999002224.SGD","LU0097036916.USD","LU0162691827.USD","LU0648001328.SGD","LU2403377893.USD","LU1032466523.USD","LU0471298777.SGD","LU0256863811.USD","IE00BZ9MQY76.HKD","IE00BFSS8Q28.SGD","LU2471134523.USD","IE00BK4W5L77.USD","BK4139","04332","PFE","LU0154236417.USD","LU2430703178.SGD","LU0072461881.USD","ELIS","LU0149725797.USD","LU1934455863.HKD","LU0114720955.EUR","LU1732800096.USD","LU2023250330.USD","IE00BKVL7J92.USD","BK4588","LU2324357040.USD","LU1244550494.USD","LU0094547139.USD","LU0203347892.USD","LU0211331839.USD","LU0496365809.HKD","LU0820561818.USD","LU0738911758.USD","LU0203345920.USD","LU1043141396.HKD","TRUH","LU0661504455.SGD","LU0265550946.USD","LU0124676726.USD","LU0985481810.HKD","FHLC","LU1670628061.USD","SG9999014567.USD","LU2089283258.USD","LU2168564222.USD","IE00BZ1G4Q59.USD","LU1121112475.USD","IE000MB6IJN5.SGD","LU2750360641.GBP","LU1145028129.USD","LU0432979614.USD","LU1571399168.USD","LU1914381329.SGD","PAWZ","LU0170899867.USD","IE00B19Z9Z06.USD","XLV","LU0321505439.SGD","LU2360032135.SGD","LU0466842654.USD","IE00BK4W5M84.HKD","LU2456880835.USD","LU0795875086.SGD","LU0211326839.USD","LU2491050071.SGD","LU0098860793.USD","LU2430703095.HKD","GDOC","SGXZ31699556.SGD","LU0029864427.USD","LU0689472784.USD","LU1057294990.SGD","LU1506573853.SGD","LU1244550221.USD","LU1674673691.USD","LU0106261372.USD","LU2242646821.SGD","LU1244550577.SGD","IE000F7OJYX1.SGD","IE00BJT1NW94.SGD","LU2129689431.USD","LU1366192091.USD","LU0859254822.USD","LU0289739343.SGD","LU2602419157.SGD","RHHBY","LU1917777945.USD","LU0456855351.SGD","LU2361045086.USD","THNR","LU2236285917.USD","LU1551013342.USD","LU2129689514.USD","LU2237443622.USD","LU2362541273.HKD","LU1291159041.SGD","BK4532","LU1551013425.SGD","LU0792757196.USD","LU1868836591.USD","LU0889565916.HKD","LU1061106388.HKD","SGXZ51526630.SGD","LU2264538146.SGD","LU0266013472.USD","LU2023251221.USD","LU1929549753.HKD","UNHU","LU0321505868.SGD","LU2089984988.USD","LU0143551892.USD","LU1732799900.SGD","LU2106854487.HKD","LU2505996681.GBP","SG9999001176.USD","BK4578","LU1221951129.SGD","UNH","LU2471134879.HKD","LU0320765059.SGD","LU2462157665.USD","LU0345769128.USD","BK4154","NVS","LU2357305700.SGD","LU1119994496.HKD","LU0069063385.USD","LU0708994859.HKD","LU1059921491.USD","LU0198837287.USD","LU1066051811.HKD","LU2087621335.USD","LU1064131342.USD","SG9999018857.SGD","IE000BZT7R73.USD","SG9999017495.SGD","LU0306806265.USD","LU0471298694.HKD","LU2112291526.USD","LU1066053197.SGD","LU1720051108.HKD","LU1720051017.SGD","LU0225283273.USD","LU1934455194.USD","LU1267930573.SGD","LU0472753341.HKD","LU0786609619.USD","LU1699723380.USD","LU0477156953.USD","LU0861579265.USD","LU1894683348.USD","SG9999014914.USD","IE0001KFT4U8.USD","RXL","LU1116320901.HKD","LU1989772923.USD","LU0426417589.USD","JDOC","LU0203202063.USD","SG9999014906.USD","LU2237443895.HKD","IE0004445239.USD","LU2361044865.SGD","LU0006306889.USD","LU2237443465.HKD","LU2491049909.HKD","TMED","IE00B19Z9505.USD","BK4599","LU0820562030.AUD","LU0158827781.USD","SG9999014880.SGD","LU0994945656.USD","IE00BJJMRX11.SGD","LLII","LU0823416689.USD","SG9999003800.SGD","LU0320765646.SGD","LU0211326755.USD","LU0251132253.USD","BK4585","IE00BGHQF631.EUR","IE00BJJMRZ35.SGD","ILDR","LU2491050154.USD","LU0057025933.USD","LU1232071149.USD","LU0265550359.USD","LU2954938101.SGD","LU2242649171.HKD","LU2244417387.USD","LU1791710400.SGD","LU0128525929.USD","LU2505996509.AUD","LU1196500208.SGD","OZEM","LU0306807586.USD","LU1894683264.USD","LU2271345857.HKD","SGXZ81514606.USD","LU1712237335.SGD","LU0225284248.USD","IE00BJJMRY28.SGD","IYH","LU0820561909.HKD","LU0689626769.HKD","LU0070302665.USD","LU1548497426.USD","LU2125154935.USD","LU0310800965.SGD","IE000SO60NU8.SGD","LU1267930227.SGD","LU0345770993.USD","BK4592","LU2756315318.SGD","LU1267930490.SGD","LU1839511570.USD","NVO","SG9999018865.SGD","SG9999015945.SGD","LU2089284900.SGD","LU2265009873.SGD","LU0342679015.USD","IE00BFXG1179.USD","BIB","LU1074936037.SGD","LU0353189763.USD","LU1496350171.SGD","MRK","LU0210528500.USD","LLY","BK4504","FTXH","LU1084165304.USD","MEDI","LU2023250504.SGD","IE00B1BXHZ80.USD","LU0133085943.USD","LU0238689110.USD","LU0289739699.SGD","LU1069344957.HKD","LU0109391861.USD","LU0965508806.USD","LU0061475181.USD","BK4568","IE00BLSP4452.SGD","LU2211815571.USD","JNJ","LU0130517989.USD","LU1629891620.HKD","LU1496350502.SGD","LU2111349929.HKD","LU0726765562.USD","LU0058720904.USD","LU2468319806.SGD","IE0004445015.USD","IE00B19Z8X17.USD","IE00B2B36J28.USD","LU1941712348.USD","LU1162221912.USD","IE00B7KXQ091.USD","LU0052756011.USD","IBBQ","LU0949170772.SGD","SG9999015986.USD","IE00B4R5TH58.HKD","LU1814569148.SGD","LU0109394709.USD","LU0942090050.USD","IE00BVYPNV92.GBP","IE00B894F039.SGD","IE0002141913.USD","LU0048584097.USD","SG9999013999.USD","IE00B775H168.HKD","IE00BKDWB100.SGD","LU2063271972.USD","BK4516","PBE","IE0002270589.USD","LU1585245621.USD","LU0912757837.SGD","LU0011850046.USD","SG9999014559.SGD","IE000WAW04H5.SGD","LU2108987350.USD","IE00B1XK9C88.USD","LU0511384066.AUD","LU2552382132.HKD","LU0882574139.USD","LU1323610961.USD","LU2756315664.SGD","LU2168564495.EUR","LU0964807845.USD","IE0005OL40V9.USD","SG9999014898.SGD","SG9999015978.USD","LU2237443382.USD","IE00BDGV0183.EUR","LU0070217475.USD","LU1066051498.USD","LU0316494557.USD","LU2125909593.SGD","MHIP","SG9999014542.SGD","NVOX","LU1868837136.USD","LU1989771016.USD","LU2279689827.SGD","LU2433249047.HKD","SGXZ57979304.SGD","LU0107464264.USD","LU0545562505.USD","LU1093756325.SGD","IE00B4JS1V06.HKD","LU0787776722.HKD","IE00BKPKM429.USD","LU0882574055.USD","LU0823434740.USD","LU2213496289.HKD","TBXU","LU0354030511.USD","LU2487616109.SGD","IE00BWXC8680.SGD","LU0079474960.USD","LU0320765489.SGD","SG9999015358.SGD","LU2896262040.SGD","03165","LU0426412945.USD","LU1868836757.USD","LU2750360997.AUD","LU0889566641.SGD","LU0053666078.USD","LU1267930730.SGD","LU2237438978.USD","IE0000B7K699.USD","LU0210536198.USD","IE00BJLML261.HKD","LU0683600562.USD","LU1228905037.USD","CURE","LU0395794307.EUR","LU0187121727.USD","IE000M9KFDE8.USD","BK4566","BK4533","LU1127390331.HKD","LU2746668461.USD","LU0795875169.SGD","LU1854104046.USD","LU0130102774.USD","IE00B3T34201.USD","CANC","LU2242652126.USD","LU2168564149.EUR","LU0965509101.SGD","SG9999015341.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175995036","title":"财报前瞻｜艾伯维公司本季营收预计增11.54%，机构观点偏乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1175995036","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175995036?lang=zh_cn&edition=full","pubTime":"2026-07-24 08:03","pubTimestamp":1784851398,"startTime":"0","endTime":"0","summary":"艾伯维公司将于2026年07月31日发布最新季度财报，市场聚焦免疫与神经科核心产品节奏及利润率修复路径。市场一致预期本季度艾伯维公司营收为167.60亿美元，同比增长11.54%；调整后每股收益为3.60美元，同比增长24.84%；息税前利润为81.44亿美元，同比增长23.40%。上季度公司营收150.02亿美元，同比增长12.43%；毛利率71.88%；归属于母公司股东的净利润为6.95亿美元，净利率4.63%；调整后每股收益为2.65美元，同比增长7.72%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜艾伯维公司本季营收预计增11.54%，机构观点偏乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1135293473","title":"Genmab与艾伯维就Epcoritamab（Duobody®-CD3xCD20）治疗复发/难治性弥漫大B细胞淋巴瘤的3期EPCORE® DLBCL-1试验作出澄清","url":"https://stock-news.laohu8.com/highlight/detail?id=1135293473","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135293473?lang=zh_cn&edition=full","pubTime":"2026-07-24 04:01","pubTimestamp":1784836901,"startTime":"0","endTime":"0","summary":"Genmab与艾伯维公司（AbbVie）日前就备受关注的3期EPCORE® DLBCL-1临床试验发布了最新澄清说明。该试验旨在全面评估Epcoritamab（Duobody®-CD3xCD20）这一创新疗法在复发或难治性弥漫大B细胞淋巴瘤（DLBCL）患者中的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013425.SGD","LU0882574055.USD","LU0256863811.USD","LU1291159041.SGD","LU2125909593.SGD","LU2237443549.SGD","LU0795875086.SGD","IE00B42XCP33.USD","RXL","LU1670627923.USD","LU0122379950.USD","LU0098860793.USD","LU1037948541.HKD","LU2087621335.USD","LU2129689514.USD","LU2089984988.USD","LU0985320562.USD","LU0661504455.SGD","LU0289961442.SGD","TRUH","LU0170899867.USD","LU0320765646.SGD","LU0432979614.USD","LU2237443895.HKD","IE00BVYPNV92.GBP","IE000WAW04H5.SGD","LU0823416689.USD","IE00BBT3K403.USD","IE000SO60NU8.SGD","LU1934455863.HKD","MEDX","FHLC","BK4581","LU0545039389.USD","LU1989772840.SGD","IE000F7OJYX1.SGD","SG9999015978.USD","LU1244550577.SGD","LU0058720904.USD","SG9999015945.SGD","LU1244550494.USD","LU1934455194.USD","LU1732800096.USD","LU0417517546.SGD","LU0868494708.USD","BK4559","SG9999015952.SGD","BK4533","LU0553294199.USD","LU2133065610.SGD","IE00B19Z3B42.SGD","LU2433249047.HKD","LU0234570918.USD","LU0234572021.USD","LU1839511570.USD","LU0795875169.SGD","LU1430594728.SGD","IE00BJJMRZ35.SGD","FTXH","LU1003077747.HKD","LU1037948897.HKD","JDOC","LU1732799900.SGD","LU0965509101.SGD","LU0158827948.USD","LU1057294990.SGD","LU0689472784.USD","LU2023251221.USD","AGNG","IE000MB6IJN5.SGD","BK4139","LU2347655156.SGD","LU2089284900.SGD","LU0310799852.SGD","VHT","IE0004445239.USD","LU0203345920.USD","LU2237443622.USD","IE00BFTCPJ56.SGD","LU0456855351.SGD","LU1162221912.USD","BK4550","LU1989771016.USD","LU1244550221.USD","LU0211327993.USD","LU1670628061.USD","LU2125909247.SGD","ABBV","LU2237443465.HKD","LU0912757837.SGD","IE0002141913.USD","LU0820561818.USD","LU1983299246.USD","LU2129689605.HKD","LU0472753341.HKD","LU0289739699.SGD","LU0689626769.HKD","LU0708994859.HKD","LU1585245621.USD","LU0511384066.AUD","IE0002270589.USD","LU2237443978.SGD","SG9999001440.SGD","SG9999015986.USD","IE00BLSP4452.SGD","LU1551013342.USD","LU0128525929.USD","LU1093756168.USD","LU0124676726.USD","LU1496350171.SGD","LU0965509010.AUD","LU0965509283.SGD","PJP","LU1267930490.SGD","LU0256863902.USD","BK4534","LU1923622614.USD","LU0203347892.USD","LU1267930573.SGD","LU1061106388.HKD","IXJ","LU0310800379.SGD","GLAM","IE0000B7K699.USD","LU0069063385.USD","LU2089283258.USD","BK4585","LU0289739343.SGD","LU0738911758.USD","LU1718418525.SGD","LU0820561909.HKD","LU0114720955.EUR","IE00B4R5TH58.HKD","LU0965508806.USD","SG9999011175.SGD","LU1929549753.HKD","IE00BJT1NW94.SGD","LU0211328371.USD","IE0009355771.USD","IE000BZT7R73.USD","IYH","IE00BN8TJ469.HKD","LU2237443382.USD","IE00BDGV0183.EUR","LU0029864427.USD","LU2129689431.USD","IE00BSNM7G36.USD","LU2357627491.SGD","PPH","SG9999003800.SGD","LU0057025933.USD","LU1023059063.AUD","LU1093756325.SGD","IE00B19Z3581.USD","BK4566","IE00BVYPNW00.USD","IE00B2B36J28.USD","IE00BLSP4239.USD","LU1074936037.SGD","LU1989772923.USD","LU0859254822.USD","LU2468319806.SGD","BK4588","LU2112291526.USD","LU0942090050.USD","XLV","LU1934455277.USD","LU0861579265.USD","LU0949170772.SGD","LU1496350502.SGD","IE00B3PB1722.GBP","LU0943347566.SGD","IE00BGHQF631.EUR","LU0868494617.USD","LU0198837287.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116716506","title":"Genmab澄清：总生存期（OS）作为美国3期Epcore® DLBCL-1试验的唯一主要终点，但未能达到","url":"https://stock-news.laohu8.com/highlight/detail?id=1116716506","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116716506?lang=zh_cn&edition=full","pubTime":"2026-07-24 04:01","pubTimestamp":1784836871,"startTime":"0","endTime":"0","summary":"Genmab公司近日发布声明，对关于其3期Epcore® DLBCL-1临床试验的结果进行了进一步澄清。该公司明确指出，总生存期（OS）是此项试验在美国设定的唯一主要终点。然而，令人遗憾的是，这一关键终点最终并未能成功达到。\n此声明旨在厘清外界对试验数据的理解，避免不必要的误读。总生存期作为衡量患者从治疗开始到死亡时间的最直接指标，其未达到预期结果，对Genmab而言无疑是一个重大挫折。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443382.USD","BK4534","LU1551013342.USD","LU2237443549.SGD","SG9999003800.SGD","BK4559","LU0738911758.USD","IYH","LU0058720904.USD","LU2089984988.USD","LU0661504455.SGD","LU0965509101.SGD","LU0689472784.USD","IE000F7OJYX1.SGD","IE00BSNM7G36.USD","LU0170899867.USD","IE0009355771.USD","LU2125909593.SGD","LU1037948541.HKD","IE00BGHQF631.EUR","LU2129689605.HKD","IE00BFTCPJ56.SGD","LU0820561818.USD","LU0256863811.USD","LU2089284900.SGD","IE000WAW04H5.SGD","LU0124676726.USD","SG9999001440.SGD","SG9999015978.USD","LU0289739343.SGD","LU1023059063.AUD","IE000BZT7R73.USD","LU0820561909.HKD","BK4550","LU0456855351.SGD","BK4566","LU0795875169.SGD","IE00BVYPNV92.GBP","LU0069063385.USD","LU0823416689.USD","IE00BLSP4452.SGD","LU1929549753.HKD","LU0861579265.USD","LU0320765646.SGD","LU0965509283.SGD","LU0198837287.USD","LU1934455194.USD","LU0795875086.SGD","IE00B19Z3581.USD","IE00B3PB1722.GBP","LU0310799852.SGD","LU2087621335.USD","AGNG","LU2089283258.USD","SG9999011175.SGD","LU0203347892.USD","LU0859254822.USD","LU0965508806.USD","VHT","LU1989772840.SGD","LU1037948897.HKD","LU2023251221.USD","LU0310800379.SGD","FHLC","ABBV","LU0965509010.AUD","LU1267930573.SGD","IE000MB6IJN5.SGD","LU2129689431.USD","LU0417517546.SGD","LU0868494617.USD","LU0211328371.USD","LU0256863902.USD","LU1983299246.USD","LU1496350502.SGD","IE00B19Z3B42.SGD","LU1551013425.SGD","LU1923622614.USD","LU1732799900.SGD","LU0234572021.USD","LU1934455863.HKD","FTXH","LU1430594728.SGD","SG9999015952.SGD","LU0029864427.USD","IE0002270589.USD","PJP","IE0004445239.USD","LU0943347566.SGD","BK4533","GLAM","IE00BN8TJ469.HKD","LU1061106388.HKD","LU1934455277.USD","LU0114720955.EUR","LU1162221912.USD","LU0289739699.SGD","LU1732800096.USD","LU2357627491.SGD","BK4581","IE00BJJMRZ35.SGD","LU1291159041.SGD","LU0472753341.HKD","LU2237443622.USD","IE00B42XCP33.USD","LU0122379950.USD","LU0985320562.USD","IE00B4R5TH58.HKD","LU1244550221.USD","LU2129689514.USD","IE000SO60NU8.SGD","XLV","BK4585","LU0949170772.SGD","LU2468319806.SGD","LU2125909247.SGD","LU1670628061.USD","LU1718418525.SGD","BK4139","LU2433249047.HKD","LU0128525929.USD","LU1093756325.SGD","IE00B2B36J28.USD","LU0432979614.USD","IE00BDGV0183.EUR","LU2237443978.SGD","MEDX","LU1093756168.USD","LU1496350171.SGD","IE0002141913.USD","LU0882574055.USD","LU0511384066.AUD","LU1244550494.USD","LU0942090050.USD","LU1839511570.USD","SG9999015945.SGD","IE00BBT3K403.USD","IE0000B7K699.USD","IE00BJT1NW94.SGD","LU0289961442.SGD","LU0708994859.HKD","LU1585245621.USD","LU0098860793.USD","LU1057294990.SGD","BK4588","LU2237443895.HKD","LU1244550577.SGD","LU0211327993.USD","LU0203345920.USD","LU2112291526.USD","LU1989771016.USD","LU1003077747.HKD","LU1074936037.SGD","LU2133065610.SGD","LU1989772923.USD","LU1670627923.USD","LU0912757837.SGD","IE00BLSP4239.USD","TRUH","LU0553294199.USD","IXJ","LU0057025933.USD","LU0545039389.USD","LU1267930490.SGD","LU0689626769.HKD","SG9999015986.USD","LU0158827948.USD","LU2237443465.HKD","IE00BVYPNW00.USD","PPH","JDOC","LU0234570918.USD","RXL","LU0868494708.USD","LU2347655156.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186168369","title":"异动解读｜艾伯维公司盘中上涨3.01%，多家投行密集上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1186168369","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186168369?lang=zh_cn&edition=full","pubTime":"2026-07-16 22:26","pubTimestamp":1784212008,"startTime":"0","endTime":"0","summary":"7月16日，艾伯维公司盘中上涨3.01%，报251.72美元/股，成交额2.3亿美元。消息面上，近期多家华尔街投行密集上调艾伯维目标价。花旗集团7月15日将目标价从230美元上调至260美元；瑞银同期上调至260美元；美国银行将目标价大幅上调至276美元，并将艾伯维列为生物制药板块首选标的；加拿大皇家银行维持\"跑赢大市\"评级，目标价上调至280美元。FactSet统计显示，艾伯维当前平均评级为\"增持\"，平均目标价266.60美元。公司将于7月31日公布第二季度财报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"艾伯维公司盘中上涨3.01%，多家投行密集上调目标价","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184491056","title":"Skinmedica® 持续投资研发，深化在再生科学领域的承诺","url":"https://stock-news.laohu8.com/highlight/detail?id=1184491056","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184491056?lang=zh_cn&edition=full","pubTime":"2026-07-14 20:06","pubTimestamp":1784030794,"startTime":"0","endTime":"0","summary":"Skinmedica®正通过持续投入研发，进一步巩固其在再生科学领域的坚定承诺。这一举措彰显了该品牌致力于推动皮肤健康与再生领域前沿科技发展的长期战略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNW00.USD","LU1093756325.SGD","LU1430594728.SGD","LU2468319806.SGD","IE00BLSP4239.USD","LU0965509010.AUD","LU2357627491.SGD","LU1244550577.SGD","LU2129689514.USD","BK4588","IE0004445239.USD","BK4534","LU0289739343.SGD","IE00B42XCP33.USD","LU0124676726.USD","LU0310799852.SGD","SG9999015952.SGD","LU1037948541.HKD","BK4585","LU2129689431.USD","LU0069063385.USD","LU0128525929.USD","LU0985320562.USD","SG9999003800.SGD","LU0795875169.SGD","LU0942090050.USD","IE000F7OJYX1.SGD","LU0882574055.USD","SG9999001440.SGD","LU2087621335.USD","LU0912757837.SGD","IE000WAW04H5.SGD","LU0234572021.USD","LU1989771016.USD","LU0949170772.SGD","IE0002141913.USD","LU0965509283.SGD","IE00BVYPNV92.GBP","LU2237443465.HKD","LU0256863902.USD","LU0058720904.USD","LU2347655156.SGD","LU0823416689.USD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU0417517546.SGD","LU0661504455.SGD","LU0289961442.SGD","LU2089284900.SGD","LU0098860793.USD","LU0861579265.USD","LU0820561818.USD","BK4581","LU1057294990.SGD","IE00B19Z3581.USD","IE00BSNM7G36.USD","LU0158827948.USD","LU1585245621.USD","IXJ","LU1551013342.USD","BK4533","LU1670628061.USD","LU2237443382.USD","LU1291159041.SGD","LU1267930573.SGD","LU1732800096.USD","IE00BBT3K403.USD","LU2023251221.USD","XLV","LU0456855351.SGD","LU1718418525.SGD","LU1551013425.SGD","LU1989772840.SGD","FHLC","ABBV","LU2237443895.HKD","LU0198837287.USD","LU1732799900.SGD","LU0432979614.USD","LU1983299246.USD","SG9999015978.USD","LU1496350171.SGD","LU0472753341.HKD","LU2133065610.SGD","LU2237443549.SGD","LU0211328371.USD","LU2112291526.USD","LU0820561909.HKD","IE00BN8TJ469.HKD","IYH","IE00BGHQF631.EUR","LU1023059063.AUD","LU0868494617.USD","LU0114720955.EUR","JDOC","LU0203345920.USD","LU0289739699.SGD","LU0965508806.USD","LU1003077747.HKD","LU1037948897.HKD","BK4559","LU0689626769.HKD","LU0310800379.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU0511384066.AUD","LU1989772923.USD","RXL","LU1929549753.HKD","LU0943347566.SGD","LU2237443622.USD","LU1162221912.USD","LU0708994859.HKD","LU2089283258.USD","LU0211327993.USD","LU0553294199.USD","IE00BLSP4452.SGD","IE0002270589.USD","IE0000B7K699.USD","BK4139","IE000MB6IJN5.SGD","IE00B3PB1722.GBP","LU1093756168.USD","LU1496350502.SGD","MEDX","IE000BZT7R73.USD","BK4550","LU0029864427.USD","LU2089984988.USD","BK4566","LU0203347892.USD","LU1267930490.SGD","LU2129689605.HKD","AGNG","LU0868494708.USD","IE00B4R5TH58.HKD","LU0689472784.USD","LU1839511570.USD","VHT","LU0057025933.USD","LU0545039389.USD","LU0965509101.SGD","IE00BJT1NW94.SGD","LU0170899867.USD","FTXH","LU1244550494.USD","LU1244550221.USD","SG9999015986.USD","PPH","LU1074936037.SGD","IE00B19Z3B42.SGD","SG9999011175.SGD","LU1061106388.HKD","IE00BDGV0183.EUR","LU0256863811.USD","LU0234570918.USD","LU1934455863.HKD","LU0738911758.USD","SG9999015945.SGD","IE000SO60NU8.SGD","PJP","LU0320765646.SGD","LU0795875086.SGD","LU1934455277.USD","IE00B2B36J28.USD","LU0859254822.USD","LU1934455194.USD","LU1670627923.USD","LU2237443978.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbvie.com","stockEarnings":[{"period":"1week","weight":0.0117},{"period":"1month","weight":-0.0004},{"period":"3month","weight":0.193},{"period":"6month","weight":0.1226},{"period":"1year","weight":0.2521},{"period":"ytd","weight":0.0853}],"compareEarnings":[{"period":"1week","weight":0.0203},{"period":"1month","weight":0.0239},{"period":"3month","weight":0.0472},{"period":"6month","weight":0.1172},{"period":"1year","weight":0.2132},{"period":"ytd","weight":0.1336}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"艾伯维公司注册成立于2012年4月10日，是一家全球性的、以研究为基础的生物制药公司。Abbvie公司从事开发和销售先进的疗法，来解决一些世界上最复杂和严重的疾病。Abbvie公司的产品主要集中在慢性自身免疫性疾病领域，包括类风湿性关节炎，牛皮癣和克罗恩病，银屑病和克罗恩病;低睾酮，HIV，子宫内膜异位症;甲状腺疾病;帕金森病;和并发症的慢性肾脏疾病和囊性纤维化相关的或其他健康问题。","yearOnYearQuotes":[{"month":1,"riseRate":0.357143,"avgChangeRate":-0.019222},{"month":2,"riseRate":0.857143,"avgChangeRate":0.039081},{"month":3,"riseRate":0.714286,"avgChangeRate":0.001102},{"month":4,"riseRate":0.571429,"avgChangeRate":0.006536},{"month":5,"riseRate":0.642857,"avgChangeRate":0.004172},{"month":6,"riseRate":0.5,"avgChangeRate":0.019288},{"month":7,"riseRate":0.5,"avgChangeRate":0.011241},{"month":8,"riseRate":0.5,"avgChangeRate":0.006034},{"month":9,"riseRate":0.538462,"avgChangeRate":0.014941},{"month":10,"riseRate":0.615385,"avgChangeRate":0.007438},{"month":11,"riseRate":0.769231,"avgChangeRate":0.063841},{"month":12,"riseRate":0.692308,"avgChangeRate":0.025718}],"exchange":"NYSE","name":"艾伯维公司","nameEN":"AbbVie"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾伯维公司,ABBV,艾伯维公司股票,艾伯维公司股票老虎,艾伯维公司股票老虎国际,艾伯维公司行情,艾伯维公司股票行情,艾伯维公司股价,艾伯维公司股市,艾伯维公司股票价格,艾伯维公司股票交易,艾伯维公司股票购买,艾伯维公司股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}